GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM23922
Query DataSets for GSM23922
Status
Public on Dec 25, 2004
Title
IFNG Microglia Sample Y20 24hrs
Sample type
RNA
Source name
Primary human microglia
Organism
Homo sapiens
Extracted molecule
total RNA
Description
Interferon-gamma treated (200u/ml) primary human microglial cells at 24 hrs post exposure
Keywords = Microglia
Keywords = Interferon-gamma
Submission date
May 25, 2004
Last update date
Mar 13, 2014
Contact name
Robert Bryan Rock
E-mail(s)
brock1007@msn.com
Phone
612-624-9996
Organization name
University of Minnesota
Street address
City
Minneapolis
State/province
MN
ZIP/Postal code
55455
Country
USA
Platform ID
GPL96
Series (1)
GSE1432
Transcriptional Response of Human Microglial Cells to Interferon-gamma
Data table header descriptions
ID_REF
VALUE
Signal of IFN-gamma sample Y20 at 24hrs
ABS_CALL
Detection value
DETECTION P-VALUE
Detection p-value
Data table
ID_REF
VALUE
ABS_CALL
DETECTION P-VALUE
AFFX-BioB-5_at
466.3
P
0.001102
AFFX-BioB-M_at
1013.9
P
0.000044
AFFX-BioB-3_at
392.4
P
0.000127
AFFX-BioC-5_at
1513.7
P
0.000127
AFFX-BioC-3_at
964.6
P
0.000052
AFFX-BioDn-5_at
1321.2
P
0.000044
AFFX-BioDn-3_at
7918.1
P
0.000095
AFFX-CreX-5_at
12197.5
P
0.000044
AFFX-CreX-3_at
18364.7
P
0.000044
AFFX-DapX-5_at
29.6
A
0.165861
AFFX-DapX-M_at
12.4
A
0.440646
AFFX-DapX-3_at
6.4
A
0.937071
AFFX-LysX-5_at
24
A
0.455413
AFFX-LysX-M_at
22
A
0.51489
AFFX-LysX-3_at
3.2
A
0.52976
AFFX-PheX-5_at
7.6
A
0.814869
AFFX-PheX-M_at
5.7
A
0.904333
AFFX-PheX-3_at
22.1
A
0.574038
AFFX-ThrX-5_at
8.9
A
0.749204
AFFX-ThrX-M_at
22.8
A
0.544587
Total number of rows:
22283
Table truncated, full table size
591 Kbytes
.
Supplementary data files not provided
Processed data included within Sample table
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|